471 related articles for article (PubMed ID: 26481155)
1. Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection.
Mukherjee UA; Ong SB; Ong SG; Hausenloy DJ
Pharmacol Ther; 2015 Dec; 156():34-43. PubMed ID: 26481155
[TBL] [Abstract][Full Text] [Related]
2. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
3. The role of oxidative stress in Parkinson's disease.
Dias V; Junn E; Mouradian MM
J Parkinsons Dis; 2013; 3(4):461-91. PubMed ID: 24252804
[TBL] [Abstract][Full Text] [Related]
4. [Mitochondrial dysfunction and oxidative damages in the molecular pathology of Parkinson's disease].
Shadrina MI; Slominskiĭ PA
Mol Biol (Mosk); 2008; 42(5):809-19. PubMed ID: 18988530
[TBL] [Abstract][Full Text] [Related]
5. The Parkinson's disease-related genes act in mitochondrial homeostasis.
Sai Y; Zou Z; Peng K; Dong Z
Neurosci Biobehav Rev; 2012 Oct; 36(9):2034-43. PubMed ID: 22771336
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
Trancikova A; Tsika E; Moore DJ
Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447
[TBL] [Abstract][Full Text] [Related]
7. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
Dodson MW; Guo M
Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease.
Thomas B; Beal MF
Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
[TBL] [Abstract][Full Text] [Related]
9. Calcium signaling in Parkinson's disease.
Calì T; Ottolini D; Brini M
Cell Tissue Res; 2014 Aug; 357(2):439-54. PubMed ID: 24781149
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 protects against cell death following acute cardiac ischemia-reperfusion injury.
Dongworth RK; Mukherjee UA; Hall AR; Astin R; Ong SB; Yao Z; Dyson A; Szabadkai G; Davidson SM; Yellon DM; Hausenloy DJ
Cell Death Dis; 2014 Feb; 5(2):e1082. PubMed ID: 24577080
[TBL] [Abstract][Full Text] [Related]
11. Impact of recent genetic findings in Parkinson's disease.
Klein C; Lohmann-Hedrich K
Curr Opin Neurol; 2007 Aug; 20(4):453-64. PubMed ID: 17620882
[TBL] [Abstract][Full Text] [Related]
12. [The role of parkin in Parkinson's disease].
Miklya I; Göltl P; Hafenscher F; Pencz N
Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
[TBL] [Abstract][Full Text] [Related]
13. Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease.
Venderova K; Kabbach G; Abdel-Messih E; Zhang Y; Parks RJ; Imai Y; Gehrke S; Ngsee J; Lavoie MJ; Slack RS; Rao Y; Zhang Z; Lu B; Haque ME; Park DS
Hum Mol Genet; 2009 Nov; 18(22):4390-404. PubMed ID: 19692353
[TBL] [Abstract][Full Text] [Related]
14. Emerging pathways in genetic Parkinson's disease.
Lewis PA
FEBS J; 2008 Dec; 275(23):5747. PubMed ID: 19021751
[No Abstract] [Full Text] [Related]
15. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1.
van der Merwe C; Jalali Sefid Dashti Z; Christoffels A; Loos B; Bardien S
Eur J Neurosci; 2015 May; 41(9):1113-25. PubMed ID: 25761903
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia.
Kim T; Vemuganti R
J Cereb Blood Flow Metab; 2017 Jun; 37(6):1910-1926. PubMed ID: 28273718
[TBL] [Abstract][Full Text] [Related]
17. Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease.
Ahlskog JE
Parkinsonism Relat Disord; 2009 Dec; 15(10):721-7. PubMed ID: 19815446
[TBL] [Abstract][Full Text] [Related]
18. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein is a pathological link and therapeutic target for Parkinson's disease and traumatic brain injury.
Shahaduzzaman M; Acosta S; Bickford PC; Borlongan CV
Med Hypotheses; 2013 Oct; 81(4):675-80. PubMed ID: 23920272
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1.
Kamp F; Exner N; Lutz AK; Wender N; Hegermann J; Brunner B; Nuscher B; Bartels T; Giese A; Beyer K; Eimer S; Winklhofer KF; Haass C
EMBO J; 2010 Oct; 29(20):3571-89. PubMed ID: 20842103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
